SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Twist Bioscience Corp. (TWST) on Monday reported a loss of $31.6 million in its fiscal first quarter.
The South San Francisco, California-based company said it had a loss of 53 cents per share.
The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 62 cents per share.
The maker of synthetic DNA for the biotechnology industry posted revenue of $88.7 million in the period, also surpassing Street forecasts. Four analysts surveyed by Zacks expected $86.9 million.
For the current quarter ending in March, Twist Bioscience said it expects revenue in the range of $91 million to $93 million.
The company expects full-year revenue in the range of $372 million to $379 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TWST at https://www.zacks.com/ap/TWST
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.